A

Athyrium Capital Management, LP

24 employees

Athyrium Capital Management is a specialized asset management company focusing on investment opportunities in the global healthcare sector.

Investor insights

Sectors invested in

Biotechnology22
Health Care18
Medical14
Pharmaceutical12
Therapeutics5
Manufacturing4
Clinical Trials4
Biopharma4
Medical Device3
Life Science3
Hospital3
Cosmetics2
E-Commerce2
Wellness2
Software2
Information Technology2
Laser Hair Removal2
Acne2
eCommerce and Direct Response2
Beauty2

Funding rounds participated in

$71M sweet spot round size

Most of their 38 investments are in rounds between $35M and $110M

Investor type

Private Equity Firm

Basic info

Industry

financial services

Sectors

Financial Services
Finance
Venture Capital

Date founded

2008

Investments made

B

Basilea Pharmaceutica raised $76M on September 7, 2022

Investors: Athyrium Capital Management, LP

u

uMotif raised $25M on May 25, 2022

Investors: AlbionVC and Athyrium Capital Management, LP

R

Revance raised $300M on March 21, 2022

Investors: Athyrium Capital Management, LP

P

Puma Biotechnology, Inc. raised $10M on March 10, 2022

Investors: Athyrium Capital Management, LP

U

Undisclosed raised $100M on October 7, 2021

Investors: Athyrium Capital Management, LP

P

Puma Biotechnology, Inc. raised $125M on July 26, 2021

Investors: Armentum Partners and Athyrium Capital Management, LP

B

BioCryst Pharmaceuticals, Inc. raised $325M on December 7, 2020

Investors: Royalty Pharma and Athyrium Capital Management, LP

A

Aris Global raised undisclosed on July 1, 2019

Investors: Athyrium Capital Management, LP

S

Secura Bio, Inc. raised $90M on March 5, 2019

Investors: Athyrium Capital Management, LP

R

Recro Pharma, Inc. raised $41M on March 4, 2019

Investors: Athyrium Capital Management, LP

FAQ